Co-morbidities of persons dying of Parkinson's disease

Progress in Palliative Care

Volumn 21, Issue 3, 2013, Pages 140-145

  Lethbridge, Lynn ^a   Johnston, Grace M ^a,b   Turnbull, George ^a  

^a DALHOUSIE UNIVERSITY   (Canada)

^b Surveillance and Epidemiology Unit   (Canada)

Author keywords

Advance care planning; Co morbidity; Death certificates; Palliative care; Parkinson disease

Indexed keywords

ACUTE HEART INFARCTION; AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DEATH CERTIFICATE; DEMENTIA; DIABETES MELLITUS; DYING; ESSENTIAL HYPERTENSION; FEMALE; HUMAN; ICD-10; ICD-9; ISCHEMIC HEART DISEASE; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; NEOPLASM; PALLIATIVE THERAPY; PARKINSON DISEASE; PERIPHERAL VASCULAR DISEASE; PNEUMONIA; SEPTICEMIA;

EID: 84879893254     PISSN: 09699260     EISSN: 1743291X     Source Type: Journal    
DOI: 10.1179/1743291X12Y.0000000037     Document Type: Article

References (55)

1. Parkinson Society Canada. Parkinson information. 2009. Available from: http://www.parkinsons-society.org/pdf/news/progression.pdf [accessed 2010 Nov 1].
2. Truong DD, Bhidayasiri R, Wolters E. Management of non-motor symptoms in advanced Parkinson disease. J. Neurol. Sci 2008;266(1-2):216-28.
3. Beyer MK, Herlofson K, Arsland D, Larsen JP. Causes of death in a community-based study of Parkinson's disease. Acta Neurol Scand 2001;103(1):7-11.
4. Nuyen J, Schellevis FG, Satariano WA, et al. Comorbidity was associated with neurologic and psychiatric diseases: a general practice-based controlled study. J Clin Epidemiol 2006;59(12): 1274-84.
5. Aarsland D, Brønnick K, Ehrt U, et al. Neuropsychiatric symptoms in patients with Parkinson's disease and dementia: frequency, profile and associated care giver stress. J Neurol Neurosurg Psychiatry 2007;78(1):36-42.
6. Martignoni E, Godi L, Citterio A, et al. Comorbid disorders and hospitalisation in Parkinson's disease: a prospective study. Neurol Sci 2004;25(2):66-71.
7. Stallard E. Underlying and multiple cause mortality at advanced ages: United States 1980-1998. N Am Actuarial J 2002;6(3): 64-87.
8. Nuti A, Ceravolo R, Piccinni A, et al. Psychiatric comorbidity in a population of Parkinson's disease patients. Eur J Neurol 2004; 11(5):315-320.
9. Shulman LM, Taback RL, Bean J, Weiner WJ. Comorbidity of the nonmotor symptoms of Parkinson's disease. Mov Disord 2001;16(3):507-510.
10. Gorina Y, Lentzner H. Multiple causes of death in old age. Aging Trends 2008;(9):1-9.
11. Sehdev AES, Hutchins GM. Problems with proper completion and accuracy of the cause-of-death statement. Arch Intern Med 2001;161(2):277-284.
12. Haberfeld E, Louis E. Is Parkinson's disease-related mortality declining? Eur J Neurol 2009;16(9):964-965.
13. Pressley JC, Tang MX, Marder K, Cote LJ, Mayeux R. Disparities in the recording of Parkinson's disease on death certificates. Mov Disord 2005;20(3):315-321.
14. Goldacre MJ, Duncan M, Griffith M, Turner MR. Trends in death certification for multiple sclerosis, motor neuron disease, Parkinson's disease and epilepsy in English populations 1979-2006. J Neurol 2010;257(5):706-715.
15. Jankovic J. Parkinson's disease: clinical features and diagnosis. J Neurol Neurosurg Psychiatry 2008;79(4):368-376.
16. Hughes AJ, Daniel SE, Lees AJ. Improved accuracy of clinical diagnosis of Lewy body Parkinson's disease. Neurology 2001; 57(8):1497-9.
17. Bajaj NP, Gontu V, Birchall J, et al. Accuracy of clinical diagnosis in tremulous parkinsonian patients: a blinded video study. J Neurol Neurosurg Psychiatry 2010;81(11):1223-1228.
18. Tinetti ME, Bogardus ST, Agostini JV. Potential pitfalls of disease-specific guidelines for patients with multiple conditions. N Engl J Med 2004;351(27):2870-2874.
19. Gross CP, Mallory R, Heiat A, Krumholz HM. Reporting the recruitment process in clinical trials: who are these patients and how did they get there? Ann of Intern Med 2002;137(1):10-16.
20. Statistics Canada. Vital statistics compendium, 1996 Cat No. 84-214-XIE. 1999. Available from: http:// www.statcan.gc.ca/pub/ 84-214-x/84-214-x1996000-eng.pdf.
21. Mooney CZ, Duval RD, Duval R. Bootstrapping: a nonpara-metric approach to statistical inference. Newbury Park, CA: Sage Publications, Inc; 1993.
22. Rosenwax LK, McNamara B, Blackmore AM, Holman CDJ. Estimating the size of a potential palliative care population. Palliat Med 2005;19(7):556-562.
23. Leibson CL, Maraganore DM, Bower JH, et al. Comorbid conditions associated with Parkinson's disease: a population-based study. Mov Disord 2006;21(4):446-455.
24. Guttman M, Slaughter PM, Theriault ME, DeBoer DP, Naylor CD. Parkinsonism in Ontario: comorbidity associated with hospitalization in a large cohort. Mov Disord 2004;19(1):49-53.
25. Saint-Hilaire M. Parkinson's disease in the elderly. Med Health Rhode Island 2008;91(5):136.
26. Leoni O, Martignoni E, Cosentino M, et al. Drug prescribing patterns in Parkinson's disease: a pharmacoepidemiological survey in a cohort of ambulatory patients. Pharmacoepidemiol Drug Saf 2002;11(2):149-157.
27. Pohar SL, Allyson Jones C. The burden of Parkinson disease (PD) and concomitant comorbidities. Arch Gerontol Geriatr 2009;49(2):317-321.
28. Boyd CM, Darer J, Boult C, et al. Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases. JAMA 2005;294(6):716-724.
29. Fernandez HH, Lapane KL. Predictors of mortality among nursing home residents with a diagnosis of Parkinson's disease. Med Sci Monit 2002;8(4):241-246.
30. Pennington S, Snell K, Lee M, Walker R. The cause of death in idiopathic Parkinson's disease. Parkinsonism Rel Disord 2010; 16(7):434-437.
31. Driver JA, Kurth T, Buring JE, Gaziano JM, Logroscino G. Parkinson disease and risk of mortality: a prospective comor-bidity-matched cohort study. Neurology 2008;70(16 Part 2): 1423.
32. Zanetti R, Rosso S, Loria DI. Parkinson's disease and cancer. Cancer Epidemiol Biomarkers Prev 2007;16(6):1081.
33. Vanacore N, Spila-Alegiani S, Raschetti R, Meco G. Mortality cancer risk in parkinsonian patients: a population-based study. Neurology 1999;52(2):395-398.
34. West AB, Dawson VL, Dawson TM. To die or grow: Parkinson's disease and cancer. Trends Neurosci 2005;28(7):348-352.
35. Garber K. Parkinson's disease and cancer: the unexplored connection. J Natl Cancer Inst 2010;102(6):371-374.
36. Checkoway H, Powers K, Smith-Weller T, et al. Parkinson's disease risks associated with cigarette smoking, alcohol consumption, and caffeine intake. Am J Epidemiol 2002;155(8):732-738.
37. Thacker EL, O'Reilly EJ, Weisskopf MG, et al. Temporal relationship between cigarette smoking and risk of Parkinson disease. Neurology 2007;68(10):764-768.
38. Hong D-P, Fink AL, Uversky VN. Smoking and Parkinson's disease: does nicotine affect [alpha]-synuclein fibrillation?. Biochim Biophys Acta 2009;1794(2):282-290.
39. Morozova N, O'Reilly EJ, Ascherio A. Variations in gender ratios support the connection between smoking and Parkinson's disease. Mov Disord 2008;23(10):1414-1419.
40. Olsen JH, Friis S, Frederiksen K. Malignant melanoma and other types of cancer preceding Parkinson disease. Epidemiology 2006;17(5):582-7.
41. Lewis KG, Weinstock MA. Nonmelanoma skin cancer mortality (1988-2000): the Rhode Island follow-back study. Arch Dermatol 2004;140(7):837-842.
42. Weinstock MA, Bogaars HA, Ashley M, et al. Inaccuracies in certification of nonmelanoma skin cancer deaths. Am J Public Health 1992;82(2):278-281.
43. Canadian Cancer Society's Steering Committee on Cancer Statistics. Canadian cancer statistics 2011. Toronto, ON: Canadian Cancer Society; 2011.
44. Woodford H, Walker R. Emergency hospital admissions in idiopathic Parkinson's disease. Mov Disord 2005;20(9):1104-1108.
45. Powe NR, Jaar B, Furth SL, Hermann J, Briggs W. Septicemia in dialysis patients: incidence, risk factors, and prognosis. Kidney Int 1999;55(3):1081-1090.
46. Kryzak TJ, Sperling JW, Schleck CD, Cofield RH. Hemiarthroplasty for proximal humerus fractures in patients with Parkinson's disease. Clin Orthop Relat Res 2010;468(7): 1817-1821.
47. Burge FI, Lawson BJ, Johnston GM, Grunfeld E. A population-based study of age inequalities in access to palliative care among cancer patients. Med Care 2008;46(12):1203-1211.
48. Grunfeld E, Lethbridge L, Dewar R, et al. Towards using administrative databases to measure population-based indicators of quality of end-of-life care: testing the methodology. Palliat Med 2006;20(8):769-777.
49. O'Brien MB, Johnston GM, Gao J, Dewar R. End-of-life care for nursing home residents dying from cancer in Nova Scotia, Canada, 2000-2003. Support Care Cancer 2007;15(9):1015-1021.
50. Johnston GM, Burge FI, Boyd CJ, MacIntyre M. End-of-life population study methods. Can J Public Health 2001;92(5): 385-386.
51. Lunney JR, Lynn J, Foley DJ, Lipson S, Guralnik JM. Patterns of functional decline at the end of life. JAMA 2003;289(18): 2387-2392.
52. Tinetti ME, McAvay GJ, Murphy TE, et al. Contribution of individual diseases to death in older adults with multiple diseases. J Am Geriatr Soc 2012;60(8):1448-1456.
53. Wachterman M, Kiely DK, Mitchell SL. Reporting dementia on the death certificates of nursing home residents dying with end-stage dementia. JAMA 2008;300(22):2608-2610.
54. Fitzgerald S. Dementia often not reported on death certificates. Neur Today 2009;9(2):1-8.
55. Phillips NJ, Reay J, Martyn CN. Validity of mortality data for Parkinson's disease. J Epidemiology Community Health 1999; 53(9): 558-587.